Endosomal/Vacuolar pathway
基因
试剂
文献样例
产品评述样例
B2M
beta-2-microglobulin
总数:5
Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression. 2008 至该文献
为了研究特定人群的肿瘤浸润淋巴细胞在诊断原发性黑色素瘤切片检查中的出现可以鉴定为临床阶段Ⅱ期黑色素瘤病人,采用了Dako的B2m的抗体进行了免疫组化实验。 更多
CTSS
cathepsin S
总数:4
T-cell activation leads to reduced collagen maturation in atherosclerotic plaques of Apoe(-/-) mice. 2009 至该文献
使用Abcam羊多克隆抗组织蛋白酶S抗体来阻断和培育蛋白印记,来证明T细胞激活会阻止动脉粥样斑块中胶原的成熟。 更多
CTSV
cathepsin V
总数:2
Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornification. 2006 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
HLA E (HLA E)
major histocompatibility complex, class I, E
总数:12
ESCRT-III governs the Aurora B-mediated abscission checkpoint through CHMP4C. 2012 至该文献
为了研究ESCRT-III调控Aurora B介导的细胞脱落,采用了Serotec的FITC标记的抗MHC-I抗体进行流式细胞分选实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-F (HLA-F)
major histocompatibility complex, class I, F
总数:1
Progressive myopathy and defects in the maintenance of myotendinous junctions in mice that lack talin 1 in skeletal muscle. 2008 至该文献
为了研究talin 1在骨骼肌发育和功能中的作用,采用了Sigma的鼠抗MHCf单抗,进行免疫组化实验
oxytocinase
leucyl and cystinyl aminopeptidase
总数:4
Sensing of dietary lipids by enterocytes: a new role for SR-BI/CLA-1. 2009 至该文献
使用ABDSerotec的羊多克隆抗PLAP抗体(0300-1909)进行免疫印迹实验来来分析由顶端PPM的供给特异性引起的早期事件和肠上皮PPM传感的分子机制。 更多